Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$815,348
-$29,506 QoQ
Shares Held
27,070
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Mar 31, 2025CallValue
$307,400
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CSS LLC/IL holds $5,129,429 across 8 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,757 | $1,634,845 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
6,950 | $915,593 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
27,070 | $815,348 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
37,616 | $780,908 | |
| 5 | ZTS |
Zoetis Inc.
|
6,220 | $735,266 | |
| 6 | VTRS |
Viatris Inc
|
8,520 | $115,105 | |
| 7 | YCBD |
cbdMD, Inc.
|
137,621 | $102,114 | |
| 8 | EVO |
Evotec SE
|
12,100 | $30,250 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $815,348 | 27,070 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $844,854 | 27,070 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $697,910 | 34,550 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $307,400 | 20,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $416,527 | 27,100 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||